Adipose tissue derived mesenchymal stromal/stem cells therapy(Cell2Cure)

N/A

Report date: 2026/02/07 20:00:33

Base Information

Drug NameAdipose tissue derived mesenchymal stromal/stem cells therapy(Cell2Cure)
Drug Alias NameAdipose Tissue Derived Mesenchymal Stromal Cells (Cell2Cure)C2C_ASC110
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsAutism Spectrum DisorderIntestinal DiseasesInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCell2Cure APS
China Registration ClassN/A

Develop Information

Active CompaniesCell2Cure APS
Inactive CompaniesN/A
Active IndicationsAutism Spectrum DisorderIntestinal DiseasesInflammatory Bowel Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A